Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Cardiac Hypertrophy

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cardiac Hypertrophy in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, MM1
Belson, MG1
Wright, D1
Lu, H1
Heninger, M1
Miller, MA1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Cardiac Hypertrophy

ArticleYear
Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
    Resuscitation, 2005, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Age Distribution; Amphetamine-Related Disorders; Autopsy; Cardiomegaly; Case-Cont

2005